Showing results (141-150 of 220) with videos related to
Sort By:
Pageof 22
Expert Review of Endocrinology & Metabolism|February 10, 2019
Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's bone diseaseSheila A DoggrellExpert Opinion on Drug Metabolism & Toxicology|February 15, 2018
Sgemaglutide in type 2 diabetes - is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?Sheila A DoggrellExpert Opinion on Pharmacotherapy|November 20, 2025
Does varenicline promote abstinence in youths who vape?Sheila A DoggrellExpert Opinion on Biological Therapy|April 20, 2024
Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathySheila A DoggrellExpert Opinion on Drug Delivery|August 27, 2023
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?Sheila A DoggrellExpert Opinion on Investigational Drugs|July 3, 2026
Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?Sheila A DoggrellDrugs of Today (Barcelona, Spain : 1998)|May 10, 2003
Targets to trials in diabetic complicationsSheila A. DoggrellExpert Opinion on Pharmacotherapy|May 13, 2003
ACE inhibitors versus diuretics: ALLHAT versus ANBP2Sheila A DoggrellExpert Opinion on Investigational Drugs|May 2, 2003
The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulationSheila A DoggrellExpert Opinion on Pharmacotherapy|March 17, 2011
Treatment for relapsed Hodgkin lymphoma: refinement of chemotherapy or targeted treatment?Sheila A DoggrellPageof 22